UBS O'Connor’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $855K | Sell |
38,528
-8,523
| -18% | -$189K | 0.04% | 224 |
|
|
2025
Q1 | $875K | Buy |
+47,051
| New | +$875K | 0.03% | 187 |
|
|
2024
Q4 | – | Sell |
-50,588
| Closed | -$1.69M | – | 349 |
|
|
2024
Q3 | $1.69M | Sell |
50,588
-29,256
| -37% | -$980K | 0.04% | 195 |
|
|
2024
Q2 | $2M | Sell |
79,844
-3,181
| -4% | -$79.7K | 0.06% | 191 |
|
|
2024
Q1 | $1.87M | Sell |
83,025
-4,099
| -5% | -$92.3K | 0.05% | 182 |
|
|
2023
Q4 | $1.87M | Sell |
87,124
-37,339
| -30% | -$800K | 0.06% | 179 |
|
|
2023
Q3 | $2.24M | Hold |
124,463
| – | – | 0.04% | 228 |
|
|
2023
Q2 | $2.53M | Buy |
124,463
+8,984
| +8% | +$183K | 0.05% | 223 |
|
|
2023
Q1 | $2.51M | Buy |
+115,479
| New | +$2.51M | 0.06% | 232 |
|
|
2022
Q4 | – | Sell |
-81,668
| Closed | -$2.08M | – | 31 |
|
|
2022
Q3 | $2.08M | Buy |
81,668
+702
| +0.9% | +$17.9K | 0.02% | 614 |
|
|
2022
Q2 | $1.64M | Buy |
+80,966
| New | +$1.64M | 0.02% | 684 |
|